SARS-CoV-2 antibody immunoassays in serial samples reveal earlier seroconversion in acutely ill COVID-19 patients developing ARDS

OBJECTIVES: During the COVID-19 pandemic, SARS-CoV-2 antibody testing has been suggested for (1) screening populations for disease prevalence, (2) diagnostics, and (3) guiding therapeutic applications. Here, we conducted a detailed clinical evaluation of four Anti-SARS-CoV-2 immunoassays in samples...

Descripción completa

Detalles Bibliográficos
Autores principales: Buchholtz, Marie-Luise, Arend, Florian M., Eichhorn, Peter, Weigand, Michael, Kleinhempel, Alisa, Häusler, Kurt, Bruegel, Mathias, Holdt, Lesca M., Teupser, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118560/
https://www.ncbi.nlm.nih.gov/pubmed/33984048
http://dx.doi.org/10.1371/journal.pone.0251587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118560/
https://www.ncbi.nlm.nih.gov/pubmed/33984048
http://dx.doi.org/10.1371/journal.pone.0251587

Ejemplares similares